Author: Customer Service

CHANDLER, Ariz., July 24, 2026 (GLOBE NEWSWIRE) — (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that it has signed a definitive agreement to acquire Hailo, a provider of accelerated edge AI processors, advanced vision processing solutions, robotics processors and comprehensive AI software flows. The transaction is expected to close towards the end of the current quarter ending September 30, subject to customary closing conditions and regulatory approvals. The terms of the transaction are not being disclosed and the transaction is not expected to have a material impact on Microchip’s financial results. The proposed acquisition is expected to expand Microchip’s processing portfolio for intelligent edge systems and strengthen...

ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BIc3b3caa4c4d94098970951ede5eb5d2e Once registered, a dial-in number, unique pin, and instructions will be provided to participants. The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following...

TORONTO, July 24, 2026 (GLOBE NEWSWIRE) — McChip Resources Inc. (TSXV: MCS) (“McChip” or the “Company”) announces that, effective July 24, 2026, Mr. Carlo Rigillo has been appointed as Chief Financial Officer and Corporate Secretary of McChip and that Mr. Grant Duthie has been appointed as an independent Director of the Company. Mr. Rigillo is an experienced Chartered Professional Accountant and has over two decades of experience developing risk management frameworks and business processes at the strategic, operational and technical levels within organizations at an international and national level. Mr. Rigillo holds a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant. Mr. Duthie is a Toronto-based corporate and securities lawyer and is currently a partner at the firm Garfinkle Biderman...

ROANOKE, Va., July 24, 2026 (GLOBE NEWSWIRE) — RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal third quarter 2026 on Friday, August 7, 2026 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at https://www.rgcresources.com/investor-financial-information/. Interested parties may access the conference call by dialing toll-free 1-877-304-9269 and entering conference identification number 917621. An archive of the webcast will be available for one year at https://www.rgcresources.com/investor-financial-information/. RGC Resources, Inc. provides energy and related products and services to customers in Virginia through its operating subsidiaries Roanoke...

VERO BEACH, Fla., July 24, 2026 (GLOBE NEWSWIRE) — Bimini Capital Management, Inc. (OTCQX:BMNM) (“Bimini” or the “Company”), today announced that it will release results for the second quarter of 2026 following the close of trading on Thursday, August 6, 2026. Earnings Conference Call Details An earnings conference call and live audio webcast will be hosted Friday, August 7, 2026, at 10:00 AM ET. Participants can register and receive dial-in information at https://register-conf.media-server.com/register/BI956f0f961ba14fccbe24002f55b3cc24. A live audio webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/ooynthfk or via the investor relations section of the Company’s website at https://ir.biminicapital.com. An audio archive of the webcast will be available for 30 days...

Í fyrri tilkynningu voru þriðju endurkaup vikunnar ranglega dagsett þann 23. júlí en hið rétta er 24. júlí, sbr. eftirfarandi tafla. Í viku 30 keyptu Hagar hf. 588.000 eigin hluti að kaupverði kr. 71.148.000 eins og hér segir:Dagsetning Tími Keyptir hlutir Viðskiptaverð Kaupverð (kr.) Eigin hlutir eftir viðskipti20.7.2026 14:31 196.000 121,000 23.716.000 19.523.61421.7.2026 09:58 196.000 122,000 23.912.000 19.719.61424.7.2026 13:40 196.000 120,000 23.520.000 19.915.614    588.000 121,000 71.148.000 19.915.614Er hér um að ræða tilkynningu um kaup félagsins á eigin hlutum í samræmi við endurkaupaáætlun félagsins sem hrint var í framkvæmd þann 2. júlí 2026, sbr. tilkynningu til Kauphallar dags. 1. júlí 2026. Hagar hafa keypt samtals 2.744.000 hluti í félaginu sem samsvarar 2,95% af þeim eigin hlutum sem að hámarki verða...

Í viku 30 keyptu Hagar hf. 588.000 eigin hluti að kaupverði kr. 71.148.000 eins og hér segir:Dagsetning Tími Keyptir hlutir Viðskiptaverð Kaupverð (kr.) Eigin hlutir eftir viðskipti20.7.2026 14:31 196.000 121,000 23.716.000 19.523.61421.7.2026 09:58 196.000 122,000 23.912.000 19.719.61423.7.2026 13:40 196.000 120,000 23.520.000 19.915.614    588.000 121,000 71.148.000 19.915.614Er hér um að ræða tilkynningu um kaup félagsins á eigin hlutum í samræmi við endurkaupaáætlun félagsins sem hrint var í framkvæmd þann 2. júlí 2026, sbr. tilkynningu til Kauphallar dags. 1. júlí 2026. Hagar hafa keypt samtals 2.744.000 hluti í félaginu sem samsvarar 2,95% af þeim eigin hlutum sem að hámarki verða keyptir samkvæmt núgildandi áætlun. Kaupverð hinna keyptu hluta nemur samtals 333.592.000  kr. sem samsvarar 66,72% af þeirri fjárhæð...

Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory Evaluation Company Launches Commercial Franchise Positioned to Establish a New Standard as an FDA-Approved Bevacizumab Therapy Across the Approximately $8.5 Billion U.S. Retina Market Anticipated 12 Years of Market Exclusivity Under the Biologics Price Competition and Innovation Act (BPCIA) ISELIN, N.J., July 24, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced that the U.S. Food and Drug Administration (FDA)...

WHITE PLAINS, N.Y., July 24, 2026 (GLOBE NEWSWIRE) — NorthEast Community Bancorp, Inc. (Nasdaq: NECB) (the “Company”), the parent holding company of NorthEast Community Bank (the “Bank”), reported net income of $9.8 million, or $0.75 per basic share and $0.72 per diluted share, for the three months ended June 30, 2026 compared to net income of $11.2 million, or $0.85 per basic share and $0.82 per diluted share, for the three months ended June 30, 2025. In addition, the Company reported net income of $19.7 million, or $1.50 per basic share and $1.46 per diluted share, for the six months ended June 30, 2026 compared to net income of $21.7 million, or $1.65 per basic share and $1.60 per diluted share, for the six months ended June 30, 2025. Kenneth A. Martinek, Chairman of the Board and Chief Executive Officer, stated “We are again...